Key result
Lower potential energy index links to ~23% higher odds of light-chain cardiac amyloidosis.
Why the study?
Pressure–volume loop changes by cardiovascular magnetic resonance imaging in cardiac amyloidosis patients with preserved LVEF and their potential as subtype differential diagnostic markers remain unknown.
Does CMR-derived PV-loop analysis improve the differential diagnosis of light-chain versus transthyretin-related cardiac amyloidosis in patients with preserved LVEF?
Observational (n=140)
No
Does CMR-derived PV-loop analysis improve the differential diagnosis of light-chain versus transthyretin-related cardiac amyloidosis in patients with preserved LVEF?
CMR-derived pressure-volume loop parameters, specifically the potential energy index, combined with NT-proBNP can serve as a valuable contrast-free diagnostic approach to differentiate between light-chain and transthyretin-related cardiac amyloidosis in patients with preserved ejection fraction.
May support non-invasive AL- vs ATTR-CA differentiation in preserved-EF patients; leaves open prospective validation before clinical adoption.
Objectives To investigate pressure–volume loop (PV-loop) changes by cardiovascular magnetic resonance (CMR) imaging in cardiac amyloidosis (CA) patients with preserved left ventricular ejection fraction (LVEF), and to assess PV-loop parameters’ potential as subtype differential diagnostic markers. Materials and methods Between May 2017 and September 2023, 100 consecutive confirmed CA patients (14 transthyretin-related [ATTR-CA] and 86 light-chain [AL-CA]) and 40 age- and sex-matched healthy controls (HCs) were prospectively enrolled. PV-loop parameters were derived from CMR cine images and brachial blood pressure. Clinical and CMR parameters were compared between CA patients and HCs, as well as between CA subtypes. The correlations between PV-loop parameters and clinical and imaging parameters were assessed. Furthermore, the differential diagnostic performance of these PV-loop parameters was evaluated using the area under the receiver operating characteristic curve (ROC-AUC). Bootstrapping was performed 2000 times for internal validation. Results Compared to HCs, CA patients showed significantly lower stroke work index, potential energy index (PEI), and work efficiency (all p < 0.001). AL-CA patients had higher N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (2358.00 [IQR: 903.25, 5559.00] vs 810.00 [IQR: 269.00, 1136.01] pg/mL, p = 0.002) and lower PEI (0.13 [IQR: 0.07, 0.15] vs 0.15 [IQR: 0.13, 0.19] J/m², p = 0.025) than ATTR-CA patients. NT-proBNP (β = −1.94, OR = 0.14, 95% CI: 0.03–0.64, p = 0.016) and PEI (β = 0.20, OR = 1.23, 95% CI: 1.07–1.44, p = 0.007) were independent predictors for AL-CA vs ATTR-CA differentiation, and combining these two parameters enhanced the diagnostic performance (bootstrapping AUC 0.847). Conclusion By providing pathophysiological insights into the distinctions between AL-CA and ATTR-CA, PV-loop parameters have the potential to serve as a complementary, contrast-free approach for differential diagnosis. Key Points Question PV-loop changes by CMR in CA patients with preserved LVEF remain unknown. Findings Light-chain CA patients with preserved LVEF had higher NT-proBNP levels and lower PEI than transthyretin-related CA patients. Critical relevance statement The CMR-derived PV-loop parameters revealed pathophysiological differences between the two subtypes of CA, suggesting potential differential diagnostic value.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2026) conducted an observational in Cardiac amyloidosis with preserved left ventricular ejection fraction (n=140). Light-chain cardiac amyloidosis vs. Transthyretin-related cardiac amyloidosis was evaluated on Differentiation of light-chain from transthyretin-related cardiac amyloidosis using potential energy index (OR 1.23, 95% CI 1.07-1.44, p=0.007). In patients with cardiac amyloidosis and preserved ejection fraction, a lower potential energy index and higher NT-proBNP independently differentiated the light-chain subtype from the transthyretin-related subtype.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: